A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia.
Author | |
---|---|
Abstract |
:
Iron deficiency anaemia is common in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD) and is often treated with oral or intravenous (IV) iron therapy. This trial compared the efficacy and safety of IV iron isomaltoside 1000 (MonoferĀ®) and oral iron in NDD-CKD patients with renal-related anaemia. |
Year of Publication |
:
2016
|
Journal |
:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
|
Volume |
:
31
|
Issue |
:
4
|
Number of Pages |
:
646-55
|
ISSN Number |
:
0931-0509
|
URL |
:
https://academic.oup.com/ndt/article-lookup/doi/10.1093/ndt/gfv293
|
DOI |
:
10.1093/ndt/gfv293
|
Short Title |
:
Nephrol Dial Transplant
|
Download citation |